HCA Healthcare Inc
NYSE:HCA
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
296.7
515.85
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
HCA
stock under the Base Case scenario is
579.86
USD.
Compared to the current market price of 467.89 USD,
HCA Healthcare Inc
is
Undervalued by 19%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for HCA Healthcare Inc.
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
|
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
|
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
|
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
|
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
|
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
|
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
|
| US |
|
Universal Health Services Inc
NYSE:UHS
|
|
| ID |
S
|
Sejahteraraya Anugrahjaya Tbk PT
IDX:SRAJ
|
|
| IN |
|
Max Healthcare Institute Ltd
NSE:MAXHEALTH
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
HCA’s reliance on government reimbursement programs (Medicare and Medicaid) exposes it to impending federal funding constraints, potentially reducing profitability if reimbursement cuts outpace cost-saving measures.
Escalating labor costs, driven by nursing shortages and inflationary pressures tied to competitive wage requirements, could erode margins and limit the company’s ability to expand or invest in growth initiatives.
The company’s accelerated capital spending to modernize facilities, coupled with elevated debt levels, eliminates financial flexibility and heightens vulnerability to adverse shifts in credit markets or economic conditions.
HCA’s extensive hospital network and strong geographic footprint position it to capitalize on patient volume growth, creating leverage with insurers and driving margin expansion across its regions.
Management’s focus on operational efficiencies, including centralized purchasing and shared clinical protocols, has historically supported superior cost control, enabling robust cash flow generation and reinvestment.
A sustained shift toward outpatient services and newer service lines, such as urgent care facilities, allows HCA to diversify revenue streams, cater to changing patient preferences, and capture additional market share.
Revenue & Expenses Breakdown
HCA Healthcare Inc
Balance Sheet Decomposition
HCA Healthcare Inc
| Current Assets | 15.3B |
| Cash & Short-Term Investments | 997m |
| Receivables | 10.4B |
| Other Current Assets | 3.9B |
| Non-Current Assets | 44.5B |
| Long-Term Investments | 1.2B |
| PP&E | 32.7B |
| Intangibles | 10.3B |
| Other Non-Current Assets | 277m |
| Current Liabilities | 17.9B |
| Accounts Payable | 4.6B |
| Accrued Liabilities | 7.2B |
| Other Current Liabilities | 6.1B |
| Non-Current Liabilities | 47.2B |
| Long-Term Debt | 38.4B |
| Other Non-Current Liabilities | 8.8B |
Free Cash Flow Analysis
HCA Healthcare Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
HCA Healthcare Inc
|
Revenue
|
74.4B
USD
|
|
Cost of Revenue
|
-11.2B
USD
|
|
Gross Profit
|
63.2B
USD
|
|
Operating Expenses
|
-51.6B
USD
|
|
Operating Income
|
11.6B
USD
|
|
Other Expenses
|
-5.3B
USD
|
|
Net Income
|
6.3B
USD
|
HCA Profitability Score
Profitability Due Diligence
HCA Healthcare Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Score
HCA Healthcare Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
HCA Solvency Score
Solvency Due Diligence
HCA Healthcare Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Score
HCA Healthcare Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HCA Price Targets Summary
HCA Healthcare Inc
According to Wall Street analysts, the average 1-year price target for
HCA
is 490.21 USD
with a low forecast of 376.94 USD and a high forecast of 551.25 USD.
Dividends
Current shareholder yield for
HCA is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
HCA
stock under the Base Case scenario is
579.86
USD.
Compared to the current market price of 467.89 USD,
HCA Healthcare Inc
is
Undervalued by 19%.